A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce antibodies that can target many variants of the virus. Traditional approaches haven’t worked — largely because HIV mutates rapidly and hides key parts of itself from the…
Two HIV vaccine trials show proof of concept for pathway to broadly neutralizing antibodies
